TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18444791

Group type: EXPERIMENTAL
Intervention: Telavancin (10 mg/kg intravenously every 24 h)
Number of subjects: 1867

Group type: COMPARATOR
Intervention: Vancomycin (1 g intravenously every 12 h)
Number of subjects: 1867

Group type: EXPERIMENTAL
Intervention: Telavancin
Number of subjects: 1867

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 1867
Study: 16818273

Group type: EXPERIMENTAL
Intervention: Deferasirox 20 mg/kg
Number of subjects: 71

Group type: COMPARATOR
Intervention: Deferoxamine (DFO) 40 mg/kg
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Deferasirox (10 or 20 mg/kg)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Deferasirox
Number of subjects: 71
Study: 14501611

Group type: EXPERIMENTAL
Intervention: Transdermal 17beta‐estradiol (50 microg/day) and medroxyprogesterone acetate (10 mg/day) for 12 days per cycle
Number of subjects: 50

Group type: COMPARATOR
Intervention: Untreated women (control group)
Number of subjects: 50
Study: 11126524

Group type: EXPERIMENTAL
Intervention: Lercanidipine (10 mg once a day) for 4 weeks, followed by 20 mg once a day for non-responders for an additional 4 weeks
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Lercanidipine (10 mg once a day)
Number of subjects: 83
Study: 8568271

Group type: EXPERIMENTAL
Intervention: 10 mg/kg cA2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1 mg/kg cA2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cA2
Number of subjects: 0
Study: 2156984

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 7006664

Group type: EXPERIMENTAL
Intervention: i.v. cyclophosphamide (CY)
Number of subjects: 485

Group type: COMPARATOR
Intervention: oral melphalan with prednisone (M & P)
Number of subjects: 485

Group type: COMPARATOR
Intervention: 4-drug regimen
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: azathioprine and vincristine
Number of subjects: 485

Group type: COMPARATOR
Intervention: stop all treatment until evidence of relapse
Number of subjects: 485
Study: 31743788

Group type: EXPERIMENTAL
Intervention: Acute Tryptophan Depletion (ATD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Tryptophan supplementation (TRYP+)
Number of subjects: 30
Study: 31155516

Group type: EXPERIMENTAL
Intervention: Combined laparoscopic-vaginal radical hysterectomy
Number of subjects: 1952
Study: 28699499

Group type: EXPERIMENTAL
Intervention: Argan oil (30 ml per day for 8 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 100
Study: 26153168

Group type: EXPERIMENTAL
Intervention: Vaginal cream mixed of yogurt and honey
Number of subjects: 70

Group type: COMPARATOR
Intervention: Clotrimazole vaginal cream
Number of subjects: 70
Study: 21682844

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Twist drills
Number of subjects: 20
Study: 21300929

Group type: EXPERIMENTAL
Intervention: ABT-751 with pemetrexed (200 mg)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo with pemetrexed
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: ABT-751 with pemetrexed
Number of subjects: 171
Study: 19171808

Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 136

Group type: COMPARATOR
Intervention: Combined exercise
Number of subjects: 136

Group type: COMPARATOR
Intervention: Resistance exercise
Number of subjects: 136
Study: 17053334

Group type: EXPERIMENTAL
Intervention: Behavioral inpatient treatment (n = 130)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Psychodynamic inpatient treatment (n = 137)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 267
Study: 12753351

Group type: EXPERIMENTAL
Intervention: Thermal noxious stimulus during SWS
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Thermal noxious stimulus during REM sleep
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Thermal noxious stimulus when awake
Number of subjects: 10

Group type: COMPARATOR
Intervention: Time-of-night effect on pain perception
Number of subjects: 10
Study: 10689256

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 1259
Study: 9496173

Group type: EXPERIMENTAL
Intervention: Clerking by a specialist nurse using a standard proforma and ordering pre-operative investigations
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clerking by PRHOs who ordered investigations as is their normal practice
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Specialist nurse's performance in limited physical examination, ordering investigations, and assessing ASA grades
Number of subjects: 100
Study: 7678870

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 1645

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1645
Study: 3315923

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 121

Group type: COMPARATOR
Intervention: Ranitidine 150 mg b.i.d.
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 121
Study: 30041603

Group type: EXPERIMENTAL
Intervention: Individual Planning (IP) intervention
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Collaborative Planning (CP) intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: No-planning control condition 1
Number of subjects: 400

Group type: COMPARATOR
Intervention: No-planning control condition 2
Number of subjects: 400
Study: 27745816

Group type: EXPERIMENTAL
Intervention: ASIR‐V (50%)
Number of subjects: 35

Group type: COMPARATOR
Intervention: ASIR (30%, 50%, and 70%)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ASIR‐V (70%)
Number of subjects: 35
Study: 22377275

Group type: EXPERIMENTAL
Intervention: Vacuum assisted closure (VAC®)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Shoelace technique
Number of subjects: 50
Study: 21447749

Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of two lessons, an Internet site, and sexual health services at school sites.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methods derived from social cognitive theory, elaboration likelihood model, persuasive communication matrix, and theories about risk communication.
Number of subjects: 0
Study: 20818875

Group type: EXPERIMENTAL
Intervention: Early palliative care integrated with standard oncologic care
Number of subjects: 151

Group type: COMPARATOR
Intervention: Standard oncologic care alone
Number of subjects: 151
Study: 18061416

Group type: EXPERIMENTAL
Intervention: Beer (3 cans daily, 40 g ethanol)
Number of subjects: 20
Study: 16172182

Group type: EXPERIMENTAL
Intervention: Lumiracoxib 400 mg once daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 12881376

Group type: EXPERIMENTAL
Intervention: Regular invitation to screening (ASP)
Number of subjects: 77080

Group type: COMPARATOR
Intervention: No invitation to screening (PSP)
Number of subjects: 77080
Study: 10516931

Group type: EXPERIMENTAL
Intervention: Levofloxacin once-a-day therapy (200 mg/day for 7 days)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Levofloxacin twice-a-day therapy (200 mg/day for 7 days)
Number of subjects: 90
Study: 9032009

Group type: EXPERIMENTAL
Intervention: Multi‐Layer Perceptron (MLP) classifier
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bayes classifier
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neural network based classifiers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Human experts
Number of subjects: 0
Study: 1564134

Group type: EXPERIMENTAL
Intervention: Nitrendipine 10 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 2865177

Group type: EXPERIMENTAL
Intervention: Doxycycline and metronidazole
Number of subjects: 146

Group type: COMPARATOR
Intervention: Penicillin G/amoxicillin and metronidazole
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Presence of antichlamydial antibodies
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Presence of adnexal mass
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Use of intrauterine contraceptive device (IUD)
Number of subjects: 146
Study: 30388181

Group type: EXPERIMENTAL
Intervention: Resistance training frequency 1 time per week (F1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Resistance training frequency 2 times per week (F2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Resistance training frequency 3 times per week (F3)
Number of subjects: 36
Study: 26943343

Group type: EXPERIMENTAL
Intervention: Gonadotropin‐releasing hormone agonist (GnRHa)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 24810262

Group type: EXPERIMENTAL
Intervention: Dexamethasone 1 mg/kg
Number of subjects: 737

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 737
Study: 20840194

Group type: EXPERIMENTAL
Intervention: Reconstituted HDL (rHDL) infusion
Number of subjects: 29

Group type: COMPARATOR
Intervention: Albumin infusion (Control)
Number of subjects: 29
Study: 19845707

Group type: EXPERIMENTAL
Intervention: Composite graft consisting of anorganic bovine bone (ABB) + autologous bone (AB)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control pristine bone biopsies
Number of subjects: 90
Study: 18479177

Group type: EXPERIMENTAL
Intervention: Intravenous lornoxicam (Xefo, 2 mL, 8 mg) with normal saline 20 mL wound infiltration
Number of subjects: 60
Study: 16197446

Group type: EXPERIMENTAL
Intervention: Fludarabine plus cytarabine (Ara‐C) and idarubicin (FLAI)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Idarubicin plus Ara‐C and etoposide (ICE)
Number of subjects: 112
Study: 12629090

Group type: EXPERIMENTAL
Intervention: GnRH agonist triptorelin (GnRHa)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GnRH agonist triptorelin (GnRHa) plus calcium supplementation
Number of subjects: 48
Study: 11051935

Group type: EXPERIMENTAL
Intervention: Maternal Care Manual of the Perinatal Education Programme (PEP)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control towns (no intervention)
Number of subjects: 93
Study: 8724940

Group type: EXPERIMENTAL
Intervention: Bilateral stimulation with a weak (1 microTesla) complex magnetic field applied over the left hemisphere, the right hemisphere, or bilaterally.
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control condition (no magnetic field exposure).
Number of subjects: 35
Study: 2004846

Group type: EXPERIMENTAL
Intervention: Intermittent high-dose cyclosporin A therapy for 6 days with each course of anti-CEA (3 patients)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Continuous low-dose cyclosporin A therapy (4 patients)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Without cyclosporin A
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Repeated therapy with 131I anti-CEA
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Nadir platelet count
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Overall conclusion of the study
Number of subjects: 7
Study: 7041297

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Clindamycin-aminoglycoside
Number of subjects: 90
Study: 31711327

Group type: EXPERIMENTAL
Intervention: Intraoperative neural monitoring (IONM) during axillary dissection
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cautious nerve dissection (CND)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 22
Study: 30993615

Group type: EXPERIMENTAL
Intervention: Group decision-making in grading committees
Number of subjects: 17
Study: 30203768

Group type: EXPERIMENTAL
Intervention: Bupleurum compound medicine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oseltamivir
Number of subjects: 0
Study: 27339607

Group type: COMPARATOR
Intervention: Energy balance (EB) diet (12105 kJ)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Energy restriction (ER) diet (3039 kJ)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Energy restriction (ER) diet
Number of subjects: 8

Group type: COMPARATOR
Intervention: Energy balance (EB) diet
Number of subjects: 8
Study: 24975853

Group type: EXPERIMENTAL
Intervention: Isolated Roux-en-Y (IsoRY)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Conventional reconstruction (CR)
Number of subjects: 153
Study: 22545249

Group type: EXPERIMENTAL
Intervention: C-RPDs
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: EP-RPDs
Number of subjects: 54

Group type: COMPARATOR
Intervention: C-RPDs and EP-RPDs
Number of subjects: 54
Study: 19931204

Group type: EXPERIMENTAL
Intervention: 24 weeks PEG-IFN alpha and ribavirin treatment
Number of subjects: 807

Group type: COMPARATOR
Intervention: 48 weeks PEG-IFN alpha and ribavirin treatment
Number of subjects: 807
Study: 19097962

Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isoflurane inhalation
Number of subjects: 30
Study: 16274750

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 425

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 425
Study: 12042551

Group type: EXPERIMENTAL
Intervention: Face covered by bedclothes during REM sleep
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Face covered by bedclothes during NREM sleep
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Face covered by bedclothes
Number of subjects: 20
Study: 10442208

Group type: EXPERIMENTAL
Intervention: Tilidine/naloxone liquid formulation (50 mg/4 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ethanol-containing reference preparation (50 mg/4 mg)
Number of subjects: 12
Study: 7880100

Group type: EXPERIMENTAL
Intervention: Navelbine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taxol in combination with cisplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CPT-11
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best conventional treatment
Number of subjects: 0
Study: 2720017

Group type: EXPERIMENTAL
Intervention: fenfluramine (60 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 30122355

Group type: EXPERIMENTAL
Intervention: Endoscopic biliary drainage
Number of subjects: 54

Group type: COMPARATOR
Intervention: Percutaneous transhepatic biliary drainage
Number of subjects: 54
Study: 28654492

Group type: EXPERIMENTAL
Intervention: Group-based task-oriented intervention at school by a school assistant or physical therapist
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Group-based task-oriented intervention in a health clinic by a physical therapist
Number of subjects: 93
Study: 25705032

Group type: EXPERIMENTAL
Intervention: Healthy Weight intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physical Activity intervention
Number of subjects: 0
Study: 23327617

Group type: EXPERIMENTAL
Intervention: Analytic reasoning group
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 145
Study: 22093888

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) group; infusion of 0.4 µg×kg(‐1)×h(‐1) for 10 min, adjusted between 0.2 and 0.4 µg×kg(‐1)×h(‐1) to maintain BIS around 80.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group; equivalent volume of normal saline administered.
Number of subjects: 30
Study: 18303127

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg qd
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel 300 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel alone (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg
Number of subjects: 0
Study: 16464383

Group type: EXPERIMENTAL
Intervention: Patient controlled intravenous ketamine analgesia (PCIKA) with intravenous small dose ketamine (20 g/L + droperidol 50 mg/L)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Patient controlled intravenous ketamine and fentanyl analgesia (PCIKFA) with intravenous small dose ketamine (10 g/L + fentanyl 5 mg/L + droperidol 50 mg/L)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional analgesia therapy (group CAT) with intramuscular injection of pethidine 50 mg and phenergan 25 mg
Number of subjects: 45
Study: 12749433

Group type: EXPERIMENTAL
Intervention: TGZ-600 (600 mg/day)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: TGZ-150 (150 mg/day)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: TGZ-300 (300 mg/day)
Number of subjects: 305
Study: 11055149

Group type: EXPERIMENTAL
Intervention: 3-hr exposure to low-intensity noise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control condition (quiet)
Number of subjects: 40
Study: 8822042

Group type: EXPERIMENTAL
Intervention: Sauna bathing session (three 10 min. stays at 85-95 degrees, relative humidity 25-30%)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control session
Number of subjects: 7
Study: 1578921

Group type: EXPERIMENTAL
Intervention: Regimen with both early and late intensification
Number of subjects: 1614

Group type: COMPARATOR
Intervention: Standard induction without intensification
Number of subjects: 1614
Study: 2420153

Group type: EXPERIMENTAL
Intervention: Irradiation plus bleomycin
Number of subjects: 46

Group type: COMPARATOR
Intervention: Irradiation
Number of subjects: 46
Study: 30076437

Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic lumbar discectomy (PELD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Microsurgical laminotomy (ML)
Number of subjects: 40
Study: 29908178

Group type: EXPERIMENTAL
Intervention: Full-spectrum endoscopy (FUSE)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Standard forward-viewing colonoscopy (SFVC)
Number of subjects: 345
Study: 26926750

Group type: EXPERIMENTAL
Intervention: Eagle Tactical Athlete Program (ETAP)
Number of subjects: 1720

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 1720
Study: 24708038

Group type: EXPERIMENTAL
Intervention: Traditional physiotherapy (exercises in lying position, 'open chain' exercises, isolated movements of extremities with trunk stabilization)
Number of subjects: 51

Group type: COMPARATOR
Intervention: New physiotherapy (exercises in vertical position, sitting or standing, 'closed chain' exercises involving whole paretic side of the body)
Number of subjects: 51
Study: 22665264

Group type: EXPERIMENTAL
Intervention: Citalopram 10 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 20606124

Group type: EXPERIMENTAL
Intervention: Integrated rSo(2) (area under the curve) for rSo(2) ≤ 45%
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Average rSo(2) during the 60-minute period after cardiopulmonary bypass
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Minimum rSo(2) during the 60-minute period after cardiopulmonary bypass
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Average rSo(2) from postinduction to 60 minutes post cardiopulmonary bypass
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Average rSo(2) during the rewarming phase
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Average rSo(2) during the 60-minute period following cardiopulmonary bypass
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Psychomotor Development Index score
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Brain hemosiderin
Number of subjects: 104
Study: 19021804

Group type: EXPERIMENTAL
Intervention: winged beans
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: ivy gourd
Number of subjects: 19

Group type: COMPARATOR
Intervention: milk
Number of subjects: 19
Study: 16041153

Group type: EXPERIMENTAL
Intervention: Pravastatin 10-20 mg/day
Number of subjects: 361

Group type: COMPARATOR
Intervention: Diet only
Number of subjects: 361
Study: 12020958

Group type: EXPERIMENTAL
Intervention: Testosterone-treated elderly men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Young controls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated elderly men
Number of subjects: 0
Study: 10443837

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection to thyroarytenoid muscles only
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection to both thyroarytenoid muscles and strap muscles
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group (not treated)
Number of subjects: 5
Study: 7576396

Group type: EXPERIMENTAL
Intervention: BNP infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 2148176

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Loratadine 20 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg and 20 mg
Number of subjects: 12
Study: 88194

Group type: EXPERIMENTAL
Intervention: Azatadine maleate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine sulfate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of azatadine and pseudoephedrine
Number of subjects: 0
Study: 29907999

Group type: EXPERIMENTAL
Intervention: Instructed Cheating (n = 107)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Self-Initiated Cheating (n = 142)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Control (no explicit instructions to cheat)
Number of subjects: 433
Study: 30783814

Group type: EXPERIMENTAL
Intervention: Afatinib 40 mg/day
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Afatinib dose reduction (< 40 mg/day)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Gefitinib 250 mg/day
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Afatinib and gefitinib beyond progression
Number of subjects: 319
Study: 28488943

Group type: EXPERIMENTAL
Intervention: Blue-blocking (BB) glasses
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clear glasses (placebo)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 25182625

Group type: EXPERIMENTAL
Intervention: Spirometry - FEV1%predicted
Number of subjects: 3080

Group type: EXPERIMENTAL
Intervention: Spirometry - FEV1/FVC
Number of subjects: 3080

Group type: EXPERIMENTAL
Intervention: Pulmonary CT biomarker - perc15
Number of subjects: 3080

Group type: EXPERIMENTAL
Intervention: Pulmonary CT biomarker - pi10
Number of subjects: 3080

Group type: EXPERIMENTAL
Intervention: Coronary artery calcium volume
Number of subjects: 3080
Study: 24325051

Group type: EXPERIMENTAL
Intervention: Wenxin Granule (WG), 9 g each time, three times daily for 90 days
Number of subjects: 65

Group type: COMPARATOR
Intervention: Routine therapies (ACEI and metoprolol)
Number of subjects: 65